Most tumor types have elevated levels of A-to-I editing and ADAR1 expression, and this latter finding has been associated with a reduction in patient survival in glioma, papillary thyroid and uterine corpus endometrial carcinomas [9]. This evidence concerns the gene ADAR and neoplasm.